Generic drugs: needs and issues
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York
Nova Science Publishers
2009
|
Schriftenreihe: | Health care issues, costs, and access
|
Schlagworte: | |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | 157 p |
ISBN: | 9781613243725 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044088219 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 170217s2009 |||| o||u| ||||||eng d | ||
020 | |a 9781613243725 |c Online |9 978-1-61324-372-5 | ||
035 | |a (ZDB-30-PAD)EBC3019437 | ||
035 | |a (ZDB-89-EBL)EBL3019437 | ||
035 | |a (OCoLC)705945748 | ||
035 | |a (DE-599)BVBBV044088219 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 338.4/76151 |2 22 | |
245 | 1 | 0 | |a Generic drugs |b needs and issues |c Ryan S. Blanton, editor |
264 | 1 | |a New York |b Nova Science Publishers |c 2009 | |
300 | |a 157 p | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Health care issues, costs, and access | |
500 | |a Includes bibliographical references and index | ||
505 | 0 | |a Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office | |
650 | 4 | |a Generic drugs |z United States | |
651 | 4 | |a USA | |
700 | 1 | |a Blanton, Ryan S. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-60692-843-1 |
912 | |a ZDB-30-PAD | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029495064 |
Datensatz im Suchindex
_version_ | 1804177139477512192 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV044088219 |
collection | ZDB-30-PAD |
contents | Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office |
ctrlnum | (ZDB-30-PAD)EBC3019437 (ZDB-89-EBL)EBL3019437 (OCoLC)705945748 (DE-599)BVBBV044088219 |
dewey-full | 338.4/76151 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 338 - Production |
dewey-raw | 338.4/76151 |
dewey-search | 338.4/76151 |
dewey-sort | 3338.4 576151 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01623nmm a2200361zc 4500</leader><controlfield tag="001">BV044088219</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2009 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781613243725</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-61324-372-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3019437</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3019437</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)705945748</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044088219</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generic drugs</subfield><subfield code="b">needs and issues</subfield><subfield code="c">Ryan S. Blanton, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">157 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Health care issues, costs, and access</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Generic drugs</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blanton, Ryan S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-60692-843-1</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029495064</subfield></datafield></record></collection> |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV044088219 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:43:20Z |
institution | BVB |
isbn | 9781613243725 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029495064 |
oclc_num | 705945748 |
open_access_boolean | |
physical | 157 p |
psigel | ZDB-30-PAD |
publishDate | 2009 |
publishDateSearch | 2009 |
publishDateSort | 2009 |
publisher | Nova Science Publishers |
record_format | marc |
series2 | Health care issues, costs, and access |
spelling | Generic drugs needs and issues Ryan S. Blanton, editor New York Nova Science Publishers 2009 157 p txt rdacontent c rdamedia cr rdacarrier Health care issues, costs, and access Includes bibliographical references and index Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office Generic drugs United States USA Blanton, Ryan S. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-1-60692-843-1 |
spellingShingle | Generic drugs needs and issues Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office Generic drugs United States |
title | Generic drugs needs and issues |
title_auth | Generic drugs needs and issues |
title_exact_search | Generic drugs needs and issues |
title_full | Generic drugs needs and issues Ryan S. Blanton, editor |
title_fullStr | Generic drugs needs and issues Ryan S. Blanton, editor |
title_full_unstemmed | Generic drugs needs and issues Ryan S. Blanton, editor |
title_short | Generic drugs |
title_sort | generic drugs needs and issues |
title_sub | needs and issues |
topic | Generic drugs United States |
topic_facet | Generic drugs United States USA |
work_keys_str_mv | AT blantonryans genericdrugsneedsandissues |